{"name":"Novartis","permalink":"novartis","crunchbase_url":"http://www.crunchbase.com/company/novartis","homepage_url":"http://www.novartis.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":null,"alias_list":"","email_address":"","phone_number":"41-61-324-11-11","description":"","created_at":"Wed Dec 24 12:27:57 UTC 2008","updated_at":"Mon Jan 09 22:04:31 UTC 2012","overview":"<p>Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in each of these areas. In 2008, the GroupÂ’s continuing operations achieved net sales of USD 41.5 billion and net income of USD 8.2 billion. Approximately USD 7.2 billion was invested in R&amp;D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 99,000 full-time-equivalent associates and operate in more than 140 countries around the world.</p>","image":{"available_sizes":[[[150,35],"assets/images/resized/0007/3011/73011v1-max-150x150.jpg"],[[163,39],"assets/images/resized/0007/3011/73011v1-max-250x250.jpg"],[[163,39],"assets/images/resized/0007/3011/73011v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"Assoc. Director Research Computing","person":{"first_name":"Cris","last_name":"De Luca","permalink":"cris-de-luca","image":{"available_sizes":[[[130,150],"assets/images/resized/0012/3155/123155v2-max-150x150.jpg"],[[217,250],"assets/images/resized/0012/3155/123155v2-max-250x250.jpg"],[[276,317],"assets/images/resized/0012/3155/123155v2-max-450x450.jpg"]],"attribution":""}}}],"competitions":[],"providerships":[{"title":"Web Conference","is_past":true,"provider":{"name":"Birchwood Group","permalink":"birchwood-group","image":{"available_sizes":[[[150,21],"assets/images/resized/0003/2400/32400v2-max-150x150.png"],[[250,35],"assets/images/resized/0003/2400/32400v2-max-250x250.png"],[[450,63],"assets/images/resized/0003/2400/32400v2-max-450x450.png"]],"attribution":null}}},{"title":"","is_past":false,"provider":{"name":"MotiveQuest","permalink":"motivequest","image":{"available_sizes":[[[150,148],"assets/images/resized/0011/3676/113676v6-max-150x150.jpg"],[[180,178],"assets/images/resized/0011/3676/113676v6-max-250x250.jpg"],[[180,178],"assets/images/resized/0011/3676/113676v6-max-450x450.jpg"]],"attribution":null}}}],"total_money_raised":"$0","funding_rounds":[],"investments":[],"acquisition":null,"acquisitions":[{"price_amount":620000000,"price_currency_code":"USD","term_code":null,"source_url":"http://www.novartis.com/newsroom/media-releases/en/2009/1366823.shtml","source_description":"Novartis to acquire Corthera Inc., gaining worldwide rights to Phase III project relaxin for treatment of acute decompensated heart failure","acquired_year":2009,"acquired_month":12,"acquired_day":23,"company":{"name":"Corthera","permalink":"corthera","image":{"available_sizes":[[[150,41],"assets/images/resized/0005/2839/52839v1-max-150x150.jpg"],[[229,64],"assets/images/resized/0005/2839/52839v1-max-250x250.jpg"],[[229,64],"assets/images/resized/0005/2839/52839v1-max-450x450.jpg"]],"attribution":null}}}],"offices":[{"description":"","address1":"","address2":"","zip_code":"CH-4002","city":"Basel","state_code":null,"country_code":"CHE","latitude":null,"longitude":null}],"milestones":[{"description":"plans to expand its global headquarters in Cambridge by adding 400,000 square feet and hiring 300 workers over the next five years","stoned_year":2010,"stoned_month":10,"stoned_day":27,"source_url":"http://www.masshightech.com/stories/2010/10/25/daily25-Novartis-to-add-jobs-expand-Cambridge-site.html","source_text":null,"source_description":"Novartis to add jobs, expand Cambridge site","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Novartis","permalink":"novartis"}},{"description":"plans to expand its global headquarters in Cambridge by adding 400,000 square feet and hiring 300 workers over the next five years","stoned_year":2010,"stoned_month":10,"stoned_day":27,"source_url":"http://www.masshightech.com/stories/2010/10/25/daily25-Novartis-to-add-jobs-expand-Cambridge-site.html","source_text":null,"source_description":"Novartis to add jobs, expand Cambridge site","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Novartis","permalink":"novartis"}},{"description":"discontinuing late stage clinical trials for a drug candidate to treat lung cancer because the trial was unlikely to meet its endpoint. ","stoned_year":2010,"stoned_month":11,"stoned_day":11,"source_url":"http://www.masshightech.com/stories/2010/11/08/daily47-Novartis-halts-lung-cancer-trial.html","source_text":null,"source_description":"Novartis halts lung cancer trial","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Novartis","permalink":"novartis"}},{"description":"Foundation Medicine has inked a collaboration deal with Novartis AG to tailor Foundationâ€™s genome-based tests to Novartisâ€™ needs","stoned_year":2011,"stoned_month":1,"stoned_day":4,"source_url":"http://www.masshightech.com/stories/2011/01/03/daily22-Foundation-Medicine-Novartis-team-up-on-cancer-diagnostics.html","source_text":null,"source_description":"Foundation Medicine, Novartis team up on cancer diagnostics","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Novartis","permalink":"novartis"}},{"description":"Foundation Medicine has inked a collaboration deal with Novartis AG to tailor Foundationâ€™s genome-based tests to Novartisâ€™ needs","stoned_year":2011,"stoned_month":1,"stoned_day":4,"source_url":"http://www.masshightech.com/stories/2011/01/03/daily22-Foundation-Medicine-Novartis-team-up-on-cancer-diagnostics.html","source_text":null,"source_description":"Foundation Medicine, Novartis team up on cancer diagnostics","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Novartis","permalink":"novartis"}},{"description":"Foundation Medicine has inked a collaboration deal with Novartis AG to tailor Foundationâ€™s genome-based tests to Novartisâ€™ needs","stoned_year":2011,"stoned_month":1,"stoned_day":4,"source_url":"http://www.masshightech.com/stories/2011/01/03/daily22-Foundation-Medicine-Novartis-team-up-on-cancer-diagnostics.html","source_text":null,"source_description":"Foundation Medicine, Novartis team up on cancer diagnostics","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Novartis","permalink":"novartis"}}],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,126],"assets/images/resized/0007/3012/73012v1-max-150x150.jpg"],[[250,210],"assets/images/resized/0007/3012/73012v1-max-250x250.jpg"],[[450,379],"assets/images/resized/0007/3012/73012v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}